Jewish Women Declare Victory on Supreme Court BRCA Gene Mutation Case

Barrier To Testing for 'Jewish' Cancer Gene Is Removed

courtesy of Lisa schlager

By Anne Cohen

Published June 13, 2013.
  • Print
  • Share Share
  • Single Page

(page 2 of 2)

“We’re very excited, over the moon,” she added. “This will really open up the ability of other tests to be developed. This is a strong message and a victory for the community that we serve.”

For Lisa Schlager, an official with FORCE, this news was a long time coming.

“I’m thrilled, I feel like this has been an ongoing battle for the past two years, and there have been so many question marks and so many opinions on how this might hinder research,” she said. “I think that nothing that happens naturally in our bodies should be patentable, and the Supreme Court obviously agrees. “

Schlager, 46, pointed out that in addition to lowering costs, this decision would potentially enable genetic clinics and counseling services that already provide testing to also test for the BRCA mutations. This especially relevant in the Jewish community, where testing for common genetic diseases like Tay Sachs is a well-developed and organized practice.

“We are big advocates of genetic counseling and an ideal place would be a Jewish genetics service that already does testing for the community,” she said. “We would love to see some of the genetic services offer this as part of their genetic testing routine for families. It could be very useful information for family planning.”

As for the partial ruling, Schlager said it was expected. “If a company develops a test that will isolate DNA certainly they should be able to patent that. What doesn’t make sense to me is to be able to patent something that occurs naturally.”

But though the ruling has been seen as a partial victory for Myriad by some, Ellen Matloff, research scientist in genetics and director of cancer genetic counseling at the Yale School of Medicine, that is not really the case.

“It is really misunderstanding the ruling to think this is a partial victory for Myriad. Believe me, its not,” Matloff wrote in an email. “This means that they have lost their patents and their exclusive monopoly. This means that other labs will immediately be offering BRCA testing. I expect that within the next 3 months. And the race is on for cheaper, faster, better testing in the long run — I expect this within the year, if not sooner.

“In the longer run, today is a huge victory for patients because research in the BRCA world will now open up,” she added. “[You can] expect the pace of research to accelerate 20 fold within the next 2 years.”

But as Joanna Rudnick pointed out, the fight for hereditary cancer awareness is far from over.

“We need to get the data back,” she explained. “That’s the next movement I’m going to get involved with. Myriad has not been publishing data [about BRCA mutations] since 2006. It’s in our hands to get that data out there and work with clinicians and reseachers.”

“I feel that justice has been done today,” she said. “But I feel there’s a lot more work to be done. We can’t stop here. “


The Jewish Daily Forward welcomes reader comments in order to promote thoughtful discussion on issues of importance to the Jewish community. In the interest of maintaining a civil forum, The Jewish Daily Forwardrequires that all commenters be appropriately respectful toward our writers, other commenters and the subjects of the articles. Vigorous debate and reasoned critique are welcome; name-calling and personal invective are not. While we generally do not seek to edit or actively moderate comments, our spam filter prevents most links and certain key words from being posted and The Jewish Daily Forward reserves the right to remove comments for any reason.





Find us on Facebook!
  • From Gene Simmons to Pink — Meet the Jews who rock:
  • The images, which have since been deleted, were captioned: “Israel is the last frontier of the free world."
  • As J Street backs Israel's operation in Gaza, does it risk losing grassroots support?
  • What Thomas Aquinas might say about #Hamas' tunnels:
  • The Jewish bachelorette has spoken.
  • "When it comes to Brenda Turtle, I ask you: What do you expect of a woman repressed all her life who suddenly finds herself free to explore? We can sit and pass judgment, especially when many of us just simply “got over” own sexual repression. But we are obliged to at least acknowledge that this problem is very, very real, and that complete gender segregation breeds sexual repression and unhealthy attitudes toward female sexuality."
  • "Everybody is proud of the resistance. No matter how many people, including myself, disapprove of or even hate Hamas and its ideology, every single person in Gaza is proud of the resistance." Part 2 of Walid Abuzaid's on-the-ground account of life in #Gaza:
  • After years in storage, Toronto’s iconic red-and-white "Sam the Record Man" sign, complete with spinning discs, will return to public view near its original downtown perch. The sign came to symbolize one of Canada’s most storied and successful Jewish family businesses.
  • Is $4,000 too much to ask for a non-member to be buried in a synagogue cemetery?
  • "Let’s not fall into the simplistic us/them dichotomy of 'we were just minding our business when they started firing rockets at us.' We were not just minding our business. We were building settlements, manning checkpoints, and filling jails." What do you think?
  • PHOTOS: 10,000 Israel supporters gathered for a solidarity rally near the United Nations in New York yesterday.
  • Step into the Iron Dome with Tuvia Tenenbom.
  • What do you think of Wonder Woman's new look?
  • "She said that Ruven Barkan, a Conservative rabbi, came into her classroom, closed the door and turned out the lights. He asked the class of fourth graders to lie on the floor and relax their bodies. Then, he asked them to pray for abused children." Read Paul Berger's compelling story about a #Savannah community in turmoil:
  • from-cache

Would you like to receive updates about new stories?




















We will not share your e-mail address or other personal information.

Already subscribed? Manage your subscription.